Logo image of MPH.CA

MEDICURE INC (MPH.CA) Stock Fundamental Analysis

Canada - TSX-V:MPH - CA58469E4085 - Common Stock

1.1 CAD
0 (0%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, MPH scores 3 out of 10 in our fundamental rating. MPH was compared to 24 industry peers in the Biotechnology industry. The financial health of MPH is average, but there are quite some concerns on its profitability. MPH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MPH has reported negative net income.
MPH had a positive operating cash flow in the past year.
MPH had negative earnings in 4 of the past 5 years.
MPH had a positive operating cash flow in 4 of the past 5 years.
MPH.CA Yearly Net Income VS EBIT VS OCF VS FCFMPH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.99%, MPH belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of -8.88%, MPH belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
ROA -5.99%
ROE -8.88%
ROIC N/A
ROA(3y)-0.74%
ROA(5y)-4.98%
ROE(3y)-1.05%
ROE(5y)-8.57%
ROIC(3y)N/A
ROIC(5y)N/A
MPH.CA Yearly ROA, ROE, ROICMPH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With an excellent Gross Margin value of 55.47%, MPH belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
MPH's Gross Margin has been stable in the last couple of years.
MPH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5Y-1.35%
MPH.CA Yearly Profit, Operating, Gross MarginsMPH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

More info and screens

6

2. Health

2.1 Basic Checks

MPH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MPH has about the same amount of shares outstanding.
The number of shares outstanding for MPH has been reduced compared to 5 years ago.
The debt/assets ratio for MPH is higher compared to a year ago.
MPH.CA Yearly Shares OutstandingMPH.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MPH.CA Yearly Total Debt VS Total AssetsMPH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

MPH has an Altman-Z score of -1.85. This is a bad value and indicates that MPH is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.85, MPH is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
The Debt to FCF ratio of MPH is 0.90, which is an excellent value as it means it would take MPH, only 0.90 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MPH (0.90) is better than 95.83% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MPH is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.02, MPH is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.9
Altman-Z -1.85
ROIC/WACCN/A
WACC8.92%
MPH.CA Yearly LT Debt VS Equity VS FCFMPH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 1.71 indicates that MPH should not have too much problems paying its short term obligations.
MPH has a better Current ratio (1.71) than 62.50% of its industry peers.
MPH has a Quick Ratio of 1.29. This is a normal value and indicates that MPH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, MPH is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.29
MPH.CA Yearly Current Assets VS Current LiabilitesMPH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

MPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -700.00%.
Looking at the last year, MPH shows a very negative growth in Revenue. The Revenue has decreased by -30.70% in the last year.
Measured over the past years, MPH shows a very strong growth in Revenue. The Revenue has been growing by 30.82% on average per year.
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-30.7%
Revenue growth 3Y-11.7%
Revenue growth 5Y30.82%
Sales Q2Q%29.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MPH.CA Yearly Revenue VS EstimatesMPH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MPH.CA Yearly EPS VS EstimatesMPH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 1 -1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

MPH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MPH.CA Price Earnings VS Forward Price EarningsMPH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

MPH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MPH is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.83
EV/EBITDA N/A
MPH.CA Per share dataMPH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MPH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDICURE INC

TSX-V:MPH (9/19/2025, 7:00:00 PM)

1.1

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-20 2025-08-20/amc
Earnings (Next)11-24 2025-11-24
Inst Owners23.1%
Inst Owner ChangeN/A
Ins Owners26.42%
Ins Owner ChangeN/A
Market Cap11.48M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF 11.83
P/OCF 5.3
P/B 0.57
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)-1.32
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.09
FCFY8.46%
OCF(TTM)0.21
OCFY18.85%
SpS2.08
BVpS1.92
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -8.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.47%
FCFM 4.48%
ROA(3y)-0.74%
ROA(5y)-4.98%
ROE(3y)-1.05%
ROE(5y)-8.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.73%
GM growth 5Y-1.35%
F-Score2
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.9
Debt/EBITDA N/A
Cap/Depr 49.4%
Cap/Sales 5.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.29
Altman-Z -1.85
F-Score2
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)19.82%
Cap/Depr(5y)17.11%
Cap/Sales(3y)1.99%
Cap/Sales(5y)1.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.7%
Revenue growth 3Y-11.7%
Revenue growth 5Y30.82%
Sales Q2Q%29.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-200.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.32%
FCF growth 3Y-41.4%
FCF growth 5YN/A
OCF growth 1Y-20.9%
OCF growth 3Y-29.85%
OCF growth 5YN/A